Filing Details
- Accession Number:
- 0001179110-18-013429
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-04 19:30:47
- Reporting Period:
- 2018-11-30
- Accepted Time:
- 2018-12-04 19:30:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
805928 | Axogen Inc. | AXGN | Electromedical & Electrotherapeutic Apparatus (3845) | 411301878 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1492710 | Gene Gregory Freitag | 13631 Progress Blvd. Suite 400 Alachua FL 32615 | General Counsel | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-11-30 | 45,000 | $33.00 | 95,865 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Plan") adopted by the reporting person on September 7, 2018, as amended November 9, 2018. The sales resulted in the completion of the Plan so no more shares will be sold pursuant to the Plan.
- The price reported is the actual sale price for all of these shares that were sold in multiple transactions. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the sale of the shares.